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ABSTRACT 42 
Background: Dietary nitrate is an important source of nitric oxide (NO), a molecule critical 43 
for cardiovascular health. Nitrate is sequentially reduced to NO through an enterosalivary 44 
nitrate-nitrite-NO pathway that involves the oral microbiome. This pathway is considered an 45 
important adjunct pathway to the classical L-arginine-NO synthase pathway. The objective of 46 
this study was to systematically assess the evidence for dietary nitrate intake and improved 47 
cardiovascular health from both human and animal studies. 48 
Methods: A systematic literature search was performed according to PRISMA guidelines 49 
using key search terms in Medline and EMBASE databases and defined inclusion and 50 
exclusion criteria. 51 
Results: Thirty-seven articles were included on humans and fourteen articles on animals 52 
from 12,541 screened references. Data on the effects of dietary nitrate on blood pressure, 53 
endothelial function, ischaemic reperfusion injury, arterial stiffness, platelet function, and 54 
cerebral blood flow in both human and animal models were identified. Beneficial effects of 55 
nitrate on vascular health have predominantly been observed in healthy human populations 56 
while effects in populations at risk of cardiovascular disease are less clear. Few studies have 57 
investigated the long-term effects of dietary nitrate on cardiovascular disease clinical 58 
endpoints. In animal studies, there is evidence that nitrate improves blood pressure and 59 
endothelial function particularly in animal models with reduced NO bioavailability. Nitrate 60 
dose seems to be a critical factor as there is evidence of cross-talk between the two pathways 61 
of NO production. 62 
Conclusion: Evidence for a beneficial effect in humans at risk of cardiovascular disease is 63 
limited. Furthermore, there is a need to investigate the long-term effects of dietary nitrate on 64 
cardiovascular disease clinical endpoints. Further animal studies are required to elucidate the 65 
mechanisms behind the observed effects. 66 
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Introduction 68 
Cardiovascular disease is the number one cause of death globally and contributes a major 69 
burden to public health systems worldwide (1). Several observational cohort studies have 70 
found plant-based diets rich in vegetables to be associated with a lower incidence of 71 
cardiovascular disease clinical endpoints (2-4). Specific vegetable groups, such as green leafy 72 
vegetables, have been shown to be the most beneficial (5-9). There are many bioactive 73 
components in green leafy vegetables that may benefit cardiovascular health. One component 74 
that has gained research interest in the last decade is nitrate (10). 75 
Nitrate is present in all vegetables at various concentrations; however, the richest sources of 76 
nitrate are beetroot and green leafy vegetables (11). Increasing nitrate intake through the diet 77 
is one potential strategy to increase nitric oxide (NO) bioavailability (12). NO plays an 78 
important role in vascular tone and integrity, and is a vital molecule for cardiovascular health 79 
(12). Reduced NO bioavailability has been observed in individuals with cardiovascular 80 
disease (13). Strategies to increase NO in healthy individuals and those at risk of 81 
cardiovascular disease may reduce cardiovascular-related events in the wider population.  82 
Due to the increased research interest in the vascular benefits of dietary nitrate, the aim of 83 
this review is to provide an overview of dietary nitrate as a source of NO, the importance of 84 
the oral microbiome in the nitrate-nitrite-NO pathway, and dietary sources of nitrate. We have 85 
also systematically compiled evidence to date on the effects of nitrate ingestion on blood 86 
pressure, arterial stiffness, endothelial function, platelet function, and cerebral blood flow in 87 
human and animal studies. This systematic literature search was conducted using criteria 88 
outlined in the PRISMA checklist. Key search terms used in Medline and EMBASE 89 
databases are outlined in Supplemental Table 1 and inclusion and exclusion criteria in 90 
Supplemental Table 2. The PRISMA flow charts for human studies can be found in 91 
6 
 
Supplemental Figure 1 and animal studies in Supplemental Figure 2. Articles were 92 
excluded if full texts could not be accessed or the articles were not in English. 93 
Two pathways to nitric oxide 94 
Nitric oxide is an important cell signalling molecule critical for vascular homoeostasis (13). A 95 
powerful vasodilator, NO relaxes smooth muscle tissue and increases regional blood flow 96 
(14). Nitric oxide also inhibits platelet and leukocyte adhesion to the vessel wall, delaying the 97 
onset of atherogenesis (15). Nitric oxide is generated through the L-arginine-NOS pathway 98 
and the recently described enterosalivary nitrate-nitrite-NO pathway. 99 
L-arginine-NOS pathway 100 
Nitric oxide is synthesised predominantly through the classical L-arginine NO synthase 101 
(NOS) pathway (16) which involves three types of NOS isoforms. These include neuronal 102 
NOS (nNOS or NOS-1), cytokine-inducible NOS (iNOS or NOS-2), and endothelial NOS 103 
(eNOS or NOS-3) (17). Due to the large mass of the endothelium within the body, eNOS is a 104 
major contributor to NO production. The regulation of eNOS activity is via intracellular 105 
calcium (Ca2+) (18) and several signal transduction pathways, including phosphoinoside 3-106 
kinase (PI3K) and adenylate cyclase (AC) pathways (19). An increase in shear stress, cyclic 107 
strain or receptor activation of vascular endothelium by biochemical stimuli (bradykinin, 108 
acetylcholine, thrombin, adenosine diphosphate, and serotonin) causes a release of Ca2+ from 109 
intracellular stores, stimulating eNOS activity (17, 20). Phosphorylation of several residues 110 
on the eNOS dimer is also an important requirement for activation (19). Equimolar amounts 111 
of NO and L-citrulline are produced using L-arginine and molecular oxygen together with 112 
tetrahydrobiopterin (BH4) in a complex oxygen-dependent five electron-transfer reaction (18, 113 
21). 114 
Nitric oxide synthesised from L-arginine in the endothelium diffuses across the cell 115 
membrane to nearby smooth muscle cells stimulating soluble guanylate cyclase (sGC) (18). 116 
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This results in the synthesis of cyclic guanosine monophosphate (cGMP) from guanosine 117 
triphosphate (GTP), triggering the relaxation of smooth muscle cells (18). Uncoupling of 118 
eNOS, by reduced bioavailability of BH4 or the substrate L-arginine, can lead to the 119 
production of superoxide or H2O2 (22). Furthermore, studies have demonstrated that reduced 120 
tissue levels of BH4 and increased superoxide generation are associated with risk factors for 121 
atherosclerosis (23-25). 122 
Nitrate-nitrite-NO pathway 123 
Historically, nitrate and nitrite have been considered to be environmental pollutants and 124 
potential carcinogenic residues in the food chain (26). Now, however, nitrate and nitrite are 125 
considered important molecules for cardiovascular health (27). 126 
Vegetables are a major source of nitrate consumed in the human population (28). When 127 
nitrate is ingested, it is absorbed in the proximal area of the small intestine (12). Nitrate then 128 
enters the bloodstream and mixes with endogenous sources of nitrate (mainly derived from 129 
oxidation of NO through the L-arginine-NOS pathway). Approximately 75% of circulating 130 
nitrate is excreted by the kidneys. The rest (~25%) is actively taken up by the salivary glands 131 
where nitrate is concentrated in saliva and secreted in the oral cavity (29, 30). Nitrate is then 132 
reduced to nitrite by facultative anaerobic bacteria found in the deep clefts on the dorsal 133 
surface of the tongue (31). The commensal bacteria in the oral cavity use nitrate as an 134 
alternative electron acceptor to oxygen during respiration, reducing nitrate to nitrite by nitrate 135 
reductases (32). Once swallowed, a proportion of nitrite is rapidly protonated forming nitrous 136 
acid (HNO2) in the acidic environment of the stomach (33). Nitrous acid decomposes further 137 
to form NO, having localised benefits (33). This non-enzymatic reduction of nitrite to NO is 138 
enhanced by vitamin C and polyphenols (34, 35). The remaining nitrate and nitrite in the 139 
stomach enter the small intestine and are absorbed into the bloodstream where they mix with 140 
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endogenous forms of nitrate and nitrite (mainly derived from oxidation of NO through the L-141 
arginine-NOS pathway). 142 
The one-electron reduction of nitrite to NO in the blood and tissues is catalysed by both 143 
enzymatic and non-enzymatic pathways (10). Enzymatic pathways include a number of 144 
proteins and enzymes including globins (such as haemoglobin, myoglobin, cytoglobin, and 145 
neuroglobin), xanthine oxidoreductase, cytochrome P450, mitochondrial proteins, carbonic 146 
anhydrase, aldehyde oxidase and eNOS (10). Non-enzymatic pathways include protons, 147 
polyphenols, and vitamin C (10). Both enzymatic and non-enzymatic reductions of nitrite to 148 
NO are enhanced during hypoxia and at a low pH (10, 36). Recent evidence suggests that the 149 
acidic environment of the stomach plays an important role in the reduction of nitrite to NO 150 
(37). 151 
The nitrate-nitrite-NO pathway and the L-arginine-NOS pathway are interconnected through 152 
the anions, nitrate and nitrite. Nitrate and nitrite are the oxidation end products of NO 153 
metabolism through the L-arginine-NOS pathway but can also be derived from the diet (32). 154 
Nitrate and nitrite, derived from the diet and derived as oxidation end products of NO 155 
metabolism, are both recycled through the nitrate-nitrite-NO pathway. Both pathways become 156 
a storage pool for NO production. Because the L-arginine-NOS pathway requires molecular 157 
oxygen to produce NO, nitrite reduction to NO via the nitrate-nitrite-NO pathway may form 158 
as a backup system for NO production during hypoxia. A crucial step in the nitrate-nitrite-NO 159 
pathway is nitrate to nitrite reduction by the oral microbiome. 160 
The oral microbiome 161 
The oral microbiome is the second most diverse microbial community in the human body 162 
comprising 50 – 100 billion bacteria, from over 700 prokaryotic taxa, as well as a fungal and 163 
viral flora (38). Disturbances to the composition, and therefore function, of the oral 164 
microbiome are thought to play a role in a number of diseases, including cardiovascular 165 
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disease (38). Whether this link is related in part to the nitrate-nitrite-NO pathway is garnering 166 
research interest. An important step in the nitrate-nitrite-NO pathway is the reduction of 167 
nitrate to nitrite by facultative anaerobic bacteria found in the oral cavity. Reduced oral 168 
bacterial nitrate to nitrite reduction, both in the presence and absence of dietary nitrate intake, 169 
could have detrimental effects on the circulating NO pool with subsequent vascular effects. In 170 
the presence of nitrate intake, interrupting the nitrate-nitrite-NO pathway with an antibacterial 171 
mouthwash or spitting out of saliva, prevented the resultant increase in salivary and plasma 172 
nitrite and the associated decrease in blood pressure (39, 40). In the absence of dietary nitrate 173 
intake, increases in blood pressure with concomitant decreases in salivary and plasma nitrite 174 
were observed with daily chlorhexidine based antibacterial mouthwash use in both healthy 175 
volunteers (41) and treated hypertensives (42). This could be explained by the fact that nitrate 176 
and nitrite, produced as end-products of NO metabolism, are recycled through the nitrate-177 
nitrite-NO pathway back into the circulating NO pool. Thus nitrate to nitrite reduction by the 178 
oral microbiome could play a key role in blood pressure control. The influence on other 179 
measures of vascular health has yet to be determined. 180 
The fundamental role of the oral microbiome in the nitrate-nitrite-NO pathway and possibly 181 
blood pressure control makes understanding all the factors that influence oral nitrate to nitrite 182 
reduction an important research area. Indeed, there is evidence of a considerable variation 183 
between individuals in the nitrate-reducing capacity of the oral microbiome (43). The first set 184 
of factors to consider is the use of anti-bacterial mouthwashes, anti-bacterial toothpastes, and 185 
antibiotics. Given the results of the studies described above, the widespread use of daily 186 
mouthwash in the general population is of potential concern. The mouthwash used in these 187 
studies, however, contained chlorhexidine, a strong antibacterial agent. Different effects have 188 
been observed with other types and strengths of antibacterial mouthwashes (44). To date only 189 
one study has examined the effect of antibacterial toothpaste, containing triclosan, on oral 190 
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nitrate to nitrite reduction (45), with no effect observed. These results need to be confirmed in 191 
additional studies examining the effect of mouthwash and toothpaste on oral nitrate 192 
reduction. Interestingly, epidemiological studies show that regular tooth brushing and 193 
mouthwash use, indicative of good oral hygiene, is associated with a decreased risk of 194 
hypertension and cardiovascular disease (46, 47). The effect of antibiotic use on oral nitrate 195 
to nitrite reduction has yet to be ascertained. 196 
Other important factors are those inherent to the complex oral microbial community such as 197 
bacterial genetics, the presence and influence of other microorganisms and environmental 198 
pressures. There are a number of potential nitrate-reducing taxa present in the oral 199 
microbiome. Doel et al (48) identified Veillonella spp as the most abundant nitrate-reducing 200 
genus followed by Actinomyces, Rothia and Staphylococcus spp (48). Hyde et al (49) 201 
confirmed Veillonella spp as the most abundant nitrate-reducing genus present but also 202 
detected Prevotella, Neisseria and Haemophilus at a higher abundance than Actinomyces spp. 203 
Nitrate to nitrite reduction by these bacteria is highly variable both within and between 204 
bacterial species and needs to be examined in the context of the huge interdependent 205 
microbial network in which they exist. This network comprises a heterogenous microbial 206 
community within a biofilm which communicates using a process called quorum sensing. 207 
These communities are highly complex, with all members influencing its health and vitality. 208 
Interestingly, the presence of nitrite reducers may prevent the accumulation of nitrite in the 209 
saliva and as such have a negative influence on the nitrate-nitrite-NO pathway (49). 210 
Microbial nitrate metabolism can also be altered by environmental influences such as pH and 211 
oxygen tension. A low pH in an oral microenvironment together with increased nitrate and 212 
nitrite concentration, can select for nitrate-reducing bacteria (50). Nitrate-reducing bacteria 213 
are facultative anaerobes. A low or no oxygen environment will therefore result in the nitrate 214 
reductive pathway being utilised for respiration. Other potential factors influencing nitrate to 215 
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nitrite reduction that requires future investigation include host factors such as age, diet, and 216 
oral health. 217 
The evidence of the link between oral health and cardiovascular disease being related to the 218 
nitrate-nitrite-NO pathway is strongly suggestive. Future studies will need to examine this 219 
relationship in the context of the large number of factors that could influence oral nitrate to 220 
nitrite reduction. 221 
Dietary sources of nitrate and nitrite 222 
Vegetables contribute approximately 80% of dietary nitrate intake in the human population 223 
(28, 51-54). Nitrate ingested in the diet can also be derived from other food sources such as 224 
fruits, grains, and animal products with the remainder coming from drinking water. Many 225 
countries have strict regulations to maintain low levels of nitrate in drinking water due to 226 
underlying health concerns, such as methaemoglobinaemia (55). High levels, however, have 227 
been detected in private wells in rural areas due to nitrogen-based fertiliser use in agricultural 228 
areas (56). Another controversial health concern is the addition of nitrate and nitrite to meat 229 
and their potential to form N-nitrosoamines, which are potential carcinogens (29). 230 
Compounds such as polyphenols, vitamins C and E and other antioxidants inhibit the 231 
formation of N-nitrosoamines (56). These compounds are abundant in vegetables. A large 232 
number of countries have also set maximum levels for nitrate in vegetables, particularly for 233 
lettuce and spinach, which are known to accumulate high amounts of nitrate (57). These 234 
maximum levels vary across harvest period, being higher in winter and if grown under cover, 235 
and lower in summer and if grown in open air (57). 236 
Dietary nitrite, on the other hand, contributes only a small amount to human exposure and is 237 
mainly consumed from animal-based foods such as cured meats and bacon (52). Nitrite is 238 
added to these products as a preservative and to enhance taste and appearance (52). Although 239 
a small amount of nitrite is consumed from these food sources, the majority of nitrite 240 
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exposure (70-90%) is derived from the in vivo conversion of nitrate to nitrite through 241 
endogenous pathways (58).  242 
The nitrate content of vegetables depends on many different factors including the biological 243 
properties of plants, fertiliser use, soil conditions, sun exposure, and cooking and storage 244 
methods. The biological properties of plants can influence the amount of nitrate that 245 
accumulates in that plant. For example, nitrate accumulates in different parts of the plants 246 
with the leaf and stem having the highest concentrations, and the bulb and fruit having the 247 
lowest (28). In our recently developed reference database for assessing dietary nitrate in 248 
vegetables (11), leafy vegetables were found to have the highest nitrate content, with Chinese 249 
flat cabbage and arugula containing the highest concentrations of nitrate (3000 mg/kg fresh 250 
weight). Corn, mushroom, and peas had the lowest nitrate content (<50 mg/kg fresh weight). 251 
Nitrate concentration in vegetables also differs between varieties. For example, Chinese 252 
lettuce has a 3-fold higher nitrate value than iceberg lettuce (11). 253 
Nitrogen-based fertilisers enhance the growth of plants, and thus, have an impact on how 254 
much nitrate accumulates in vegetables. Nitrate located in the soil of a growing vegetable is 255 
transported via the plant xylem system to the leaves of the vegetables (52). As organic 256 
vegetables tend to be grown in fertilisers containing less nitrogen, by comparison 257 
conventionally grown vegetables tend to accumulate higher nitrate levels (11, 59). 258 
Other factors such as handling, storage, and processing, as well as temperature and light 259 
intensity can also influence the amount of nitrate in vegetables (52). Higher nitrate levels are 260 
observed in vegetables grown in winter compared to summer, and vegetables grown under 261 
cover contain higher nitrate levels than those grown outdoors in the same season and the 262 
same region (11, 52). 263 
Storage in ambient temperature can also reduce the nitrate content of fresh vegetables. Under 264 
refrigerated and frozen storage conditions nitrate levels appear to be unaffected (52). 265 
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Endogenous nitrate reductase activity and the amount of bacterial contamination due to post-266 
harvest storage and wilting processes reduce nitrate and subsequently increase nitrite in fresh 267 
vegetables (52). Being water soluble, nitrate is also reduced with washing and cooking 268 
methods by approximately 10-15% and 50%, respectively (52). As nitrate is also found in the 269 
skin of vegetables, peeling of the skin can also reduce nitrate levels by roughly 20-34% (52). 270 
Nitrate ingestion and its effects on vascular function 271 
Dietary nitrate is now considered an important alternative source of NO. Human and animal 272 
studies to date have focused on the effects of nitrate ingestion on blood pressure, arterial 273 
stiffness, endothelial function, platelet function, and cerebral blood flow, as discussed below. 274 
A summary of the beneficial effects of nitrate ingestion on these cardiovascular-related 275 
outcomes in human and animal studies is shown in Figure 1. Benefits of nitrate ingestion on 276 
exercise performance will not be covered in this review. 277 
Blood pressure 278 
Evidence that decreased NO production was associated with hypertension raised the 279 
possibility that nitrate, through the nitrate-nitrite-NO pathway, could partially account for the 280 
blood pressure lowering effects of green leafy vegetables. Randomised controlled trials such 281 
as the Dietary Approaches to Stop Hypertension (DASH) trial have been shown to reduce 282 
blood pressure (60). It has been suggested that the high nitrate content of the DASH diet 283 
contributes to the blood pressure lowering effects observed (28). The DASH diet has been 284 
estimated to include as much as 1,222 mg (19.7 mmol) of nitrate per day (28). This amount 285 
can, however, differ by as much as 700% due to the wide variation of nitrate in vegetables 286 
(28). An Acceptable Daily Intake (ADI) of 3.7 mg nitrate per kg body weight was set by the 287 
Joint Food and Agricultural Organisation and World Health Organisation (52). For an average 288 
person weighing 70 kg, this is calculated to be 259 mg of nitrate. The DASH diet can provide 289 
up to 500% more nitrate than this ADI.  290 
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The DASH diet is associated with reductions of 4.5 mmHg in systolic blood pressure (SBP) 291 
(61). This blood pressure reduction is similar to that seen in a meta-analysis demonstrating 292 
that consumption of inorganic nitrate and nitrate-rich beetroot juice is associated with a SBP 293 
reduction of 4.4 mmHg (62). There is now substantial evidence from human intervention 294 
trials to demonstrate blood pressure reductions with short-term intake of dietary nitrate in 295 
healthy populations (62). However, the effects of chronic nitrate intake on blood pressure in 296 
older populations and populations at risk of cardiovascular disease remain uncertain (50, 63-297 
68). 298 
Human studies 299 
Our systematic literature search revealed 27 acute studies (≤24 hours) (Table 1) (40, 50, 63, 300 
69-85) and 15 chronic studies (>1 day) (Table 2) (50, 65-68, 86-93) in 32 publications 301 
investigating the effects of nitrate ingestion on blood pressure. Beetroot juice was the most 302 
common nitrate source used in both acute and chronic studies. Twenty-four hour ambulatory 303 
blood pressure (24-hour ABP), the preferred diagnostic method for assessing hypertension 304 
(94, 95), was used in 10 studies (65-68, 77, 80-82, 87, 90). Clinic blood pressure was used in 305 
34 studies (40, 50, 63, 65, 67, 69-76, 78, 79, 83-93) and four studies used home blood 306 
pressure monitoring (66, 67, 87, 90). 307 
Acute studies 308 
The acute effects of nitrate ingestion on blood pressure were investigated between 2-24 hours 309 
with nitrate doses ranging from 68-1488 mg (1.1-24 mmol) (Table 1). Five studies showed a 310 
significant reduction in SBP only (78, 82-85) and four studies showed a significant reduction 311 
in only diastolic blood pressure (DBP) (71, 77, 79, 80). Eleven studies showed significant 312 
reductions in both SBP and DBP (40, 50, 71, 72, 81, 85). Acute reductions in SBP ranged 313 
from 2.7 to 22.2 mmHg and 2.6 to 23.6 mmHg for DBP. Reductions in blood pressure were 314 
seen across the entire range of nitrate doses investigated and in subjects that were healthy (40, 315 
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71, 72, 77, 78, 80-85), overweight (79), and hypercholesterolaemic (50). Sample sizes of 316 
these populations ranged from 6 to 67 participants. Blood pressure reductions were not seen 317 
in seven studies (63, 69, 70, 73-76). These populations consisted of subjects that were healthy 318 
(69, 70, 73-76) and subjects with heart failure (63). Sample sizes of these populations ranged 319 
from 5 to 40 participants. 320 
Chronic studies 321 
The chronic effects of nitrate ingestion on blood pressure were investigated in 15 studies 322 
from 3 to 42 days (6 weeks) with nitrate doses ranging from 155-1104 mg/d (2.5-17.8 323 
mmol/d) (Table 2). Three studies showed a significant reduction in SBP (88-90) and three 324 
other studies showed a significant reduction in DBP (86, 92, 93). Only one study showed a 325 
significant reduction in both SBP and DBP (87). In total, seven studies demonstrated a 326 
significant reduction in blood pressure. It is worth noting, the study conducted by Ashworth 327 
et al (88) was not clear whether the significant reductions in blood pressure were acute or 328 
chronic as the subjects were advised to eat high nitrate vegetables 2-3 hours before blood 329 
pressure was taken on the final day. Reductions in SBP ranged from 4.0 to 8.1 mmHg and 330 
reduction in DBP ranged from 2.4 to 12 mmHg with nitrate doses ranging from 165-1104 331 
mg/d (2.7-17.8 mmol/d). Reductions in blood pressure were seen in one study using 24-hour 332 
ABP monitoring (87), two studies using home blood pressure (87, 90) and six studies using 333 
clinic blood pressure (86-89, 92, 93). Blood pressure reductions were seen in subjects that 334 
were healthy (86, 88, 92, 93), at moderate cardiovascular risk (89), older and overweight 335 
(90), and grade 1 hypertensive (treated and untreated) (87). These studies were a mix of 336 
young (mean age <37 y) (86, 88, 92, 93) and older cohorts (mean age >56 y) (87, 89, 90). 337 
Most studies demonstrating reductions in blood pressure were of low sample size (n range 6-338 
25), except Kapil et al (87), which had a sample size of n=64. 339 
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Blood pressure reductions were not seen in eight studies (50, 65-68, 91). These populations 340 
consisted of subjects that were older (91), pre-hypertensive (67), treated hypertensive (66), 341 
overweight and obese (65), type 2 diabetic (68), and hypercholesterolemic (50). These 342 
populations were all older adult populations (mean age >60 y) with larger sample sizes (n 343 
range 27-67) (50, 65-68), apart from one study which had a sample size of n=8 (91).  344 
There is now clear and convincing evidence that nitrate reduces blood pressure within hours 345 
of ingestion. The evidence of chronic ingestion of nitrate on blood pressure is less clear. 346 
Studies suggest that chronic intake of nitrate lowers blood pressure in young healthy 347 
individuals; however, these blood pressure lowering effects are not seen in older individuals 348 
and individuals at risk of cardiovascular disease. Recent evidence suggests possible 349 
interactions between sulphate and nitrate which may explain some of these inconsistencies 350 
(96). However, research is in need to further investigate this theory. 351 
Animal studies 352 
We identified 17 studies, in 12 publications, that assessed the effect of nitrate 353 
supplementation on blood pressure in an animal model (Table 8). Nitrate sources included 354 
NaNO3 (n=10), KNO3 (n=1), and Mg(NO3)2 (n=1) supplemented drinking water. Nitrate 355 
doses ranged from 0.1-4.27 mmol/kg/d and treatment time ranged from 1 week to 12 months. 356 
The number of animals in each treatment group ranged from 5 to 23. Nine studies reported a 357 
decrease in blood pressure after nitrate supplementation and five studies reported no change 358 
in blood pressure. Only one study reported an increase in blood pressure; Carlstrom et al 359 
reported a significant increase in mean arterial pressure (MAP) in healthy rats after 8 weeks 360 
of nitrate supplementation (1 mM/kg/d) (97). In the same study, a decrease in blood pressure 361 
was seen with a 0.1 mM dose of nitrate. In two studies where high blood pressure was 362 
induced, either by the use of spontaneously hypertensive rats (98, 99) or by administration of 363 
a high-fructose diet (100), nitrate supplementation prevented the increase in blood pressure 364 
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observed in the control group. In a study by Henzel et al, a decrease in MAP and SBP was 365 
only seen in old (22 months) Sprague-Dawley rats and not in young (3 months) rats (101). It 366 
is important to note that although both groups were receiving the same concentration of 367 
nitrate in their drinking water, the younger rats were receiving a much higher dose of nitrate 368 
(776 µmol/kg/d vs 290 µmol/kg/d), due to their higher water intake and lower body weight. 369 
In a study by Khalifi et al, a decrease in SBP was only seen in diabetic Wistar rats and not 370 
their healthy counterparts (102). This may be due to positive effects of nitrate 371 
supplementation on NO status and oxidative stress, which would have been compromised in 372 
the diabetic rats but not the healthy rats. Other studies have shown that higher doses of nitrate 373 
can reduce blood pressure in animal models that have been shown to have reduced NO 374 
bioavailability (100, 101, 103). 375 
Endothelial function 376 
The endothelium lines the entire vascular system and plays an essential role in the 377 
maintenance of vascular homoeostasis (104). Dysfunction of the endothelium has been 378 
identified in the development of atherosclerotic-related diseases (105). Flow-mediated 379 
dilatation (FMD) via non-invasive ultrasound measures the endothelial function of the 380 
brachial artery (106, 107). It is the gold standard method for assessing conduit artery 381 
endothelial function (106) and is significantly associated with cardiovascular disease events 382 
(108, 109). It has previously been shown from a meta-analysis of 14 prospective cohort 383 
studies that the risk of experiencing a cardiovascular event is reduced by 13% for every 1% 384 
higher in FMD (110). The degree of endothelial function is determined by the change in 385 
brachial artery diameter before and after a shear stress stimulus, induced by reactive 386 
hyperaemia (108). In the forearm vasculature, FMD provides a measure of endothelium-387 
derived NO bioavailability (111). 388 
Human studies 389 
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Our systematic literature search revealed seven acute studies (≤24 hours) (Table 3) (50, 75, 390 
76, 79, 83, 84, 112) and four chronic studies (>1 day) (Table 4) (50, 68, 87, 89) in 10 391 
publications investigating the effects of nitrate ingestion on FMD. Beetroot juice was the 392 
most common nitrate source used in both acute and chronic studies. 393 
Acute studies 394 
The acute effects of nitrate ingestion on FMD were investigated between 1.5-4 hours with 395 
nitrate doses ranging from 6-772 mg (0.1-12.4 mmol) (Table 3). The lower nitrate dose in this 396 
range was estimated using the global average body weight of 62 kg as no average body 397 
weight was reported in this study (75). Six studies demonstrated a significant improvement in 398 
FMD (50, 75, 76, 79, 83, 112) and one study demonstrated no effect (84). Improvements in 399 
FMD ranged from 0.5 to 4.0% were seen across the entire range of nitrate doses investigated. 400 
Beetroot juice was also found to attenuate the postprandial impairment of FMD following a 401 
high-fat meal (79). Improvements in FMD were seen in mainly healthy populations (75, 76, 402 
83, 112). Other populations where improvements in FMD were seen included 403 
hypercholesterolaemic (50) and overweight (79) subjects. These healthy and at risk 404 
populations consisted of three studies in younger cohorts (mean age ≤27 y) (75, 76, 112) and 405 
three studies in older cohorts (mean age >45 y) (50, 79, 83) with an overall sample size 406 
ranging from 5 to 67. No effects on FMD were observed in one healthy population of 14 407 
participants aged 28 y (84). 408 
Chronic studies  409 
The chronic effects of nitrate ingestion on FMD were investigated ranging from 14 to 42 days 410 
(2 to 6 weeks) with nitrate doses ranging from 375 to 577 mg/d (6.0 to 9.3 mmol/d) (Table 4). 411 
The higher nitrate dose in this range was estimated using the global average body weight of 412 
62 kg as no average body weight was reported in this study (89). Three studies showed a 413 
significant improvement in FMD (50, 87, 89) and one study had no effects (68). In particular, 414 
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Rammos et al (89) demonstrated dietary nitrate reversed vascular dysfunction in older adults 415 
with moderately increased cardiovascular risk. Improvements in FMD ranged from 0.5 to 416 
1.1% and were seen across the entire range of nitrate doses investigated. Increases in FMD 417 
(~1%) were seen in two studies (50, 87) using similar nitrate doses from beetroot juice (375 418 
mg/d and 398 mg/d). Ingestion of a slightly higher nitrate dose of 577 mg/d (9.3 mmol/d) 419 
using sodium nitrate showed a 0.5% improvement (89). Improvements in FMD were seen in 420 
subjects with hypercholesterolemia (50), treated and untreated hypertension (87), and 421 
moderate cardiovascular risk (89). All populations were older adult populations (mean age 422 
>50 y) with large sample sizes (>60), except one study that had a sample size of 11 (89). No 423 
effects on FMD were observed after 14 days of nitrate ingestion (beetroot juice) in 27 424 
subjects with type 2 diabetes mellitus (68). 425 
Animal studies 426 
Numerous studies have reported that blood vessels with a damaged endothelium have 427 
impaired vasorelaxation in response to acetylcholine (ACh) (Table 8) (113, 114). We 428 
identified three animal studies, from two publications, investigating the effects of dietary 429 
nitrate supplementation on endothelial function (97, 115). Bakker et al (115) demonstrated 430 
that although supplementation with very high dose nitrate (10 mmol/kg/d) had no effect on 431 
Ach-mediated vessel relaxation in a mouse model of atherosclerosis, low (0.1 mmol/kg/d) 432 
and moderate (1 mmol/kg/d) dose nitrate supplementation significantly improved the 433 
endothelial dysfunction associated with this mouse model. In addition, Carlstrom et al (97) 434 
reported that dietary supplementation with a high dose of nitrate (1 mmol/kg/d) was 435 
associated with attenuated acetylcholine-mediated vasorelaxation. These observations are in 436 
support of the theory proposed by Carlstrom et al that there is cross-talk between the two 437 
pathways of NO production. They suggest that high doses of dietary nitrate may inhibit 438 
production of NO through the L-arginine-NOS pathway, leading to a net decrease in the 439 
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amount of NO reaching the smooth muscle cells of the blood vessel (97). Although Bakker et 440 
al showed improvements with a 1 mmol/kg/d dose of nitrate and Carlstrom et al reported no 441 
improvements with the same dose, the animal model used is likely an important factor as the 442 
Apolipoprotein-E knock-out mice used in the study by Bakker et al (115) have reduced NO 443 
bioavailability. 444 
Ischaemic reperfusion injury 445 
Ischaemic reperfusion injury is tissue damage caused by a period of ischemia or lack of 446 
oxygen. Lack of oxygen during an ischaemic period results in inflammation and oxidative 447 
damage leading to microvascular dysfunction (116). Local and systemic tissue ischemia 448 
remains the major cause of death from cardiovascular disease (1). As the nitrate-nitrite-NO 449 
pathway is enhanced in times of hypoxia, this pathway may provide a back up to the classical 450 
L-arginine-NO synthase pathway.  451 
Human studies 452 
Our systematic literature search revealed three acute studies (two publications) investigating 453 
the effects of nitrate ingestion on ischaemic reperfusion injury (Table 5) (40, 85). Beetroot 454 
juice was the most common nitrate source used. The acute effects of nitrate ingestion on 455 
ischaemic reperfusion injury were investigated between 2-3 hours with nitrate doses ranging 456 
from 341-1488 mg (5.5-24 mmol) (Table 5). Benefits were also seen in all studies where 457 
beetroot juice (40, 85) and potassium nitrate (85) attenuated ischaemia reperfusion-induced 458 
endothelial dysfunction measured using FMD. Improvements were seen in young (mean age 459 
<28 y), healthy populations (40, 85) with an overall sample size ranging from 10 to 12. 460 
Animal studies 461 
We found only one study describing the effects of dietary nitrate supplementation on 462 
ischaemia-induced revascularisation in an animal model (Table 8). In a study by Hendgen-463 
Cotta et al, mice were treated with either nitrate (1 g/L NaNO3 in drinking water) or NaCl 464 
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(control) for 14 days (117). Perfusion recovery in the ischaemic hind limb was significantly 465 
improved in mice treated with nitrate compared with controls via a significant increase in 466 
capillary density. These results suggest that dietary nitrate supplementation may represent a 467 
novel strategy to enhance ischaemia-induced revascularization. 468 
Arterial stiffness 469 
Pulse wave velocity (PWV) is a measure of aortic stiffness and is a strong predictor of 470 
cardiovascular events (118-120). Pulse wave velocity is recognised as the most simple, non-471 
invasive, robust and reproducible technique to determine arterial stiffness and is considered 472 
the gold-standard measurement of arterial stiffness (121). Pulse wave velocity measures 473 
arterial stiffness by dividing the estimated distance between the carotid and femoral arteries 474 
by the pulse transit time, the time delay between the carotid and femoral waveforms. A 475 
tonometer is used to capture the carotid waveform and a cuff is placed around the femoral 476 
artery to capture the femoral waveform. Augmentation index (AIx) is another measure of 477 
arterial stiffness which provides a composite measure of elastic plus muscular artery stiffness 478 
and wave reflection. Augmentation index has also been shown to be an independent predictor 479 
of future cardiovascular disease events (122). 480 
Human studies 481 
Our systematic literature search revealed seven acute studies (≤24 hours) (50, 70, 72, 78-80, 482 
84) and 5 chronic studies (>1 day) (50, 65, 67, 87, 89) in 10 publications investigating the 483 
effects of nitrate consumption on arterial stiffness (Table 6). Beetroot juice was the most 484 
common nitrate source used in both acute and chronic studies. 485 
Acute studies 486 
The acute effects of nitrate ingestion on arterial stiffness were investigated between 2-6 hours 487 
with nitrate doses ranging from 68-583 mg (1.1-9.4 mmol) (Table 6). Three studies 488 
demonstrated a significant decrease in arterial stiffness (50, 72, 84) and four studies 489 
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demonstrated no effect (70, 78-80). A significant decrease of 0.3 m/s in PWV was observed 490 
in two studies (50, 84) with a nitrate dose of 375 mg (6 mmol) from beetroot juice (50) and 491 
496 mg (8 mmol) from potassium nitrate (84). The study by Velmurugan et al (50) consisted 492 
of a large sample size of 67 hypercholesterolaemic men and women with a mean age of 53 y, 493 
whereas the study by Bahra et al (84) consisted of a smaller sample of 14 healthy individuals 494 
with a mean age 28 y. Hughes et al (72) demonstrated a reduced AIx in young, but not old, 495 
adults following a nitrate dose of 583 mg (9.4 mmol). No effect was seen in four studies with 496 
nitrate doses ranging from 68-500 mg (1.1-8.1 mmol) using beetroot juice (70, 79), beetroot-497 
enriched bread (80), and spinach (78). These studies consisted of healthy (70, 78, 80) and 498 
overweight (79) subjects. 499 
Chronic studies 500 
The chronic effects of nitrate ingestion on arterial stiffness were investigated from 7 to 42 501 
days (1 to 6 weeks) with nitrate doses ranging from 300-600 mg/d (4.8-9.7 mmol/d) (Table 502 
6). Three studies demonstrated a significant decreased in arterial stiffness after nitrate 503 
ingestion (50, 87, 89) and two studies demonstrated no effect (65, 67). Studies found a 504 
significant decrease of 0.2-1.2 m/s in PWV with nitrate doses ranging from 375-577 mg/d (6-505 
9.3 mmol/d) using beetroot juice and sodium nitrate (577 mg/d was estimated using the 506 
global average body weight of 62 kg as no average body weight was reported in this study 507 
(89)). The populations where an effect was observed had moderate cardiovascular risk (89), 508 
untreated and treated hypertension (87), and hypercholesterolemia (50). No effect was seen in 509 
two studies with nitrate doses of 300 mg/d (4.8 mmol/d) from green leafy vegetables (67) and 510 
600 mg/d (9.7 mmol/d) from beetroot juice (65); populations that were overweight and obese 511 
(65) and pre-hypertensive (67). It has been demonstrated that for every 3.4 m/s in increase in 512 
PWV, the risk of experiencing a cardiovascular event is increased by 17% (118). Therefore, a 513 
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decrease of 0.2-1.2 m/s in PWV is likely to provide a small but significant reduction in the 514 
risk of experiencing a cardiovascular disease event. 515 
Animal studies 516 
Upon search of the literature, we found no animal studies investigating the effects of dietary 517 
nitrate supplementation on arterial stiffness. 518 
Platelet function  519 
Platelets play a major role in the acute complications of atherosclerosis in the late stages of 520 
the disease, which can subsequently lead to atherosclerotic-related events (123). Nitric oxide 521 
has been shown to inhibit platelet aggregation and adhesion to the endothelial wall (124) and 522 
there is now evidence to suggest dietary nitrate may repress platelet reactivity. 523 
Human studies 524 
Our systematic literature search identified five acute studies (≤24 hours) (40, 125, 126) and 525 
one chronic study (>1 day) (50), in four publications, investigating the effects of nitrate 526 
intake on platelet function (Table 7). Potassium nitrate was the most common nitrate source 527 
used in acute studies whilst beetroot juice was used in the chronic study.  528 
Acute studies 529 
The acute effects of nitrate ingestion on platelet function were investigated between 2.5-3 530 
hours with nitrate doses between 31-1054 mg (0.5-17 mmol) (Table 7). All five studies 531 
demonstrated reductions in platelet aggregation and reactivity (40, 125, 126). Velmurugan et 532 
al (125) demonstrated that nitrate ingestion decreased platelet reactivity in healthy males, but 533 
not in healthy females. This was observed with both beetroot juice (192 mg or 3.1 mmol) and 534 
potassium nitrate (496 mg or 8 mmol). Further studies using beetroot juice (1054 mg or 17 535 
mmol) (40) and potassium nitrate (31 mg and 124 mg or 0.5 and 2 mmol) (126) demonstrated 536 
reductions in platelet aggregation. All cohorts consisted of young healthy populations and 537 
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were of small sample sizes (n<25). Further acute studies are needed to replicate these 538 
findings in older adult populations at risk of developing cardiovascular disease. 539 
Chronic studies 540 
The chronic effects of nitrate ingestion on platelet function were investigated in only one 541 
study (Table 7) (50). Velmurugan et al (50) demonstrated a reduction in platelet-monocyte 542 
aggregates after 42 days of daily beetroot juice ingestion with a nitrate dose of 375 mg/d (6 543 
mmol/d). This study had a large sample size (n=67) of older male and female adults aged 53 544 
y with hypercholesterolemia. There is a strong need for further chronic studies to investigate 545 
the effects of nitrate ingestion on platelet function in healthy populations and to replicate 546 
findings in older adult populations at risk of cardiovascular disease. 547 
Animal studies 548 
Only one animal study has been published investigating the effects of dietary nitrate 549 
supplementation on platelet function (Table 8). In this study, wild-type C57BL/6 mice were 550 
supplemented with 1 g/L NaNO3 in their drinking water for 1 week, placed on a low nitrate 551 
diet or continued on standard mice chow (control) (127). Platelet aggregation was 552 
significantly decreased in the group supplemented with nitrate and was significantly 553 
increased in the group on the low nitrate diet, in comparison to the control group. These 554 
findings demonstrate that manipulation of nitrate levels in blood, via supplementation or 555 
dietary restriction, could affect platelet function in mice, although further studies are required 556 
to corroborate this finding. 557 
Cerebral blood flow 558 
The effect of dietary nitrate on cerebral blood flow has been investigated in several studies 559 
due to the observed effects of dietary nitrate on vasodilation and increases in blood flow. 560 
Diminished blood flow to the brain is likely to contribute to the pathophysiological processes 561 
underlying vascular cognitive impairment (128).  562 
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Human studies 563 
Our systematic literature search identified one acute study (≤24 hours) (129) and one chronic 564 
study (>1 day) (130) in two publications investigating the effect of nitrate ingestion on 565 
cerebral blood flow (Table 9). Sodium nitrate and a high nitrate diet were used as nitrate 566 
sources.  567 
Acute studies 568 
Presley et al (129) demonstrated consuming a high nitrate diet (769 mg or 12.4 mmol of 569 
nitrate) over a 24 hour period increased regional cerebral perfusion in frontal lobe white 570 
matter, in older adults with a mean age of 75 y (Table 9). This was particularly evident in the 571 
dorsolateral prefrontal cortex and anterior cingulate cortex. In the same study, however, the 572 
acute effects of a high nitrate diet did not modify global cerebral perfusion.  573 
Chronic studies 574 
Aamand et al (130) demonstrated no effects after 3 days of sodium nitrate ingestion (477 575 
mg/d or 7.7 mmol/d of nitrate, based on study mean weight of 77kg) on cerebral blood flow 576 
in 20 healthy men (Table 9).  577 
Animal studies 578 
No animal studies investigating the effects of dietary nitrate supplementation on blood flow 579 
were found. 580 
Summary: nitrate ingestion and its effects on vascular function 581 
Human intervention studies have now demonstrated ingestion of nitrate lowers blood 582 
pressure and improves endothelial function. These studies are predominantly in healthy 583 
populations and are of short duration. It is yet to be established whether nitrate ingestion has 584 
the same effects in populations at higher risk of cardiovascular disease as few studies have 585 
been conducted and findings are inconsistent. Further research is also needed to understand 586 
the long-term effects of nitrate intake on cardiovascular clinical endpoints.  587 
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Epidemiological evidence  588 
Epidemiological studies have found plant-based diets rich in vegetables are associated with 589 
lower rates of cardiovascular disease (2, 4, 131-136). In particular, cohort studies have shown 590 
specific vegetable groups high in nitrate, such as green leafy vegetables, to be most beneficial 591 
(6-9). The exact mechanisms for the protective effects shown in these studies are still 592 
unknown. The Mediterranean diet (3, 137), the DASH diet (60, 138) and a vegetarian diet 593 
(139, 140), all rich in vegetables, have been shown to be particularly beneficial towards 594 
cardiovascular health. These diets are likely to contain substantially higher amounts of nitrate 595 
than the average Western diet. Thus, nitrate is one possible candidate for explaining 596 
cardiovascular health benefits seen with higher vegetable intakes (141). 597 
There are very few observational epidemiological studies investigating nitrate intake and 598 
cardiovascular-related health outcomes (Table 10). Although databases have been established 599 
to calculate the nitrate intake in observational epidemiological studies (142-144), there was a 600 
strong need for a more comprehensive database with compiled up-to-date data. Our recently 601 
developed database on the nitrate content of vegetables (11) now gives researchers the 602 
opportunity to conduct more observational epidemiological studies with an adequate 603 
assessment of nitrate intake. 604 
To date, there have been two articles published utilising the nitrate content of vegetables 605 
database (11). We have demonstrated nitrate intake to be inversely associated with 606 
atherosclerotic vascular disease mortality in a cohort of older adult women (mean age 75 ± 3 607 
y) (53). In comparison to lower intakes of nitrate from vegetables <53 mg/d (median 39 608 
mg/d), the inverse relationship with atherosclerotic vascular disease mortality plateaued at 609 
intakes of 53-76 mg/d (median 63 mg/d) (53). In the same cohort of older adult women, we 610 
also observed an inverse relationship between nitrate intake from vegetables and common 611 
carotid artery intima-media thickness, as well as ischaemic cerebrovascular disease events 612 
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(hospitalisation or death) (54). The inverse relationship with ischaemic cerebrovascular 613 
disease events also plateaued at intakes of 53-76 mg/d (median 63 mg/d) (54). 614 
Prior to these studies being published, the Tehran Lipid and Glucose Study reported on the 615 
relationship between consumption of nitrate-containing vegetables and risk of hypertension 616 
(145) and chronic kidney disease (CKD) (146), both risk factors for cardiovascular disease. 617 
These studies investigated nitrate intake by assessing whole vegetables containing nitrate. 618 
The authors further categorised nitrate-containing vegetables into low-nitrate, medium-nitrate 619 
and high-nitrate vegetables. It is worth noting that these studies essentially investigated whole 620 
vegetables and then different types of vegetables according to their nitrate levels and not 621 
nitrate as a separate entity. It is, however, difficult to separate nitrate intake from vegetable 622 
intake as the two can be highly correlated; as we have previously demonstrated (r=0.75, 623 
P<0.001) (53). Golzarand et al (145) found a significant inverse association between the 624 
intake of nitrate-containing vegetables and 3-year incidence of hypertension in the highest 625 
tertile compared with the lowest tertile of nitrate-containing vegetables. There were no 626 
significant associations observed between low-nitrate, medium-nitrate and high-nitrate 627 
containing vegetables and 3-year risk of hypertension. As no associations were found 628 
between categories of nitrate-containing vegetables, it is difficult to determine whether the 629 
inverse association demonstrated with total nitrate-containing vegetables is due to vegetable 630 
intake alone. This cohort consisted of 1,546 Iranian men and women (57% women), aged 631 
38±12 years, without hypertension at baseline. In the same cohort, Mirmiran et al (146) found 632 
that the highest compared to the lowest tertile of nitrate-containing vegetables was associated 633 
with a lower estimated glomerular filtration rate and a higher prevalence of CKD at baseline. 634 
This could be a demonstration of reverse causality bias where the diagnosis of chronic 635 
disease has altered dietary intake. There was no association with the occurrence of CKD after 636 
3 years of follow-up after excluding patients with CKD at baseline. Lastly, Bahadoran et al 637 
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(147) recently reported findings on the potential effects of dietary nitrate and nitrite on the 638 
occurrence of type 2 diabetes in the same cohort of Iranian men and women (Tehran Lipid 639 
and Glucose Study). Bahadoran et al (147) reported on 2,139 adults free of type 2 diabetes at 640 
baseline with a median follow-up of 5.8 y. Nitrate and nitrite values were determined from a 641 
recent survey conducted on frequently consumed food items among Iranians (148). Nitrate 642 
and nitrite concentrations of 87 foods were determined using spectrophotometric methods. 643 
The authors found no associations between nitrate intake and the risk of developing type 2 644 
diabetes. However, the authors demonstrated an increased risk of type 2 diabetes among 645 
participants with higher intakes of total and animal-based nitrite in the presence of low 646 
vitamin C intake. The same was not observed in participants with high intakes of vitamin C 647 
(>108 mg/d) (147), suggesting that diets high in vitamin C may counteract the suggested 648 
adverse effects of nitrite on type 2 diabetes. However, higher intakes of total and animal-649 
based nitrite in the presence of low vitamin C intake may be a marker of an unhealthy diet 650 
and lifestyle that may also be associated with a higher prevalence of type 2 diabetes.  651 
There is a lingering concern that nitrate and nitrite may form cancerous compounds such as 652 
nitrosamines (10). The majority of epidemiological studies to date have investigated 653 
relationships between nitrate intake and cancer outcomes. A report compiled by the 654 
International Agency for Research on Carcinogenicity concluded “Ingested nitrate or nitrite 655 
under conditions that result in endogenous nitrosation is probably carcinogenic to humans 656 
(Group 2A)” (149). Conditions that increase endogenous nitrosation are complex but could 657 
involve interactions between the amount of nitrate and nitrite consumed, stomach acidity, 658 
smoking status, medical conditions and the low intakes of nutrients that are likely to decrease 659 
the potential for nitrosation such as polyphenols, vitamin C and vitamin E (56).  660 
Now that there is a comprehensive database on the nitrate content of vegetables available, 661 
researchers have the opportunity to further investigate the associations between chronic 662 
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intake of nitrate and health outcomes. Further research is needed to elucidate the relationships 663 
amongst different populations including young vs. older age groups, low vs. higher 664 
background nitrate intakes, and healthy vs. at risk populations.  665 
Conclusion 666 
There is now strong evidence to suggest that dietary nitrate derived from vegetables can 667 
reduce blood pressure and other markers of vascular function in healthy populations. There is 668 
a need for further research to investigate whether similar effects are observed in populations 669 
at risk of developing cardiovascular disease. Few studies have investigated the long-term 670 
effects of dietary nitrate on cardiovascular disease clinical endpoints; large observational 671 
follow-up studies are required to address this. Further animal studies are required to elucidate 672 
the mechanisms behind the observed beneficial effects. Increasing nitrate in the diet through 673 
the consumption of nitrate-rich vegetables may prove to be an achievable and cost effective 674 
way to reduce the risk of cardiovascular disease.675 
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Table 1. Intervention studies investigating the acute effects of inorganic nitrate on blood pressure in humans. 
 Blood 
pressure 
effect 
Nitrate source Nitrate dose Duration Subjects Screening/baseline 
blood pressure 
Reference 
Effect ↓ Clinic SBP  
↓ Clinic DBP 
Beetroot juice 583 mg 
(9.4 mmol) 
3 h 
 
Young: 25±4 y (10 M; 3 F)  
Old: 64±5 y (9 M; 3 F) 
Healthy 
Optimal/normal Hughes 
2016 (72) 
 ↓ Clinic DBP 
 
Sodium nitrate  800 mg  
(12.9 mmol) 
5 h 
 
28±1 y (11 M; 7 F) 
Healthy 
Optimal/Normal Jonvik 2016 
(71) 
 ↓ Clinic SBP  
↓ Clinic DBP  
Beetroot juice       
 ↓ Clinic SBP  
↓ Clinic DBP  
Rocket salad 
beverage  
     
 ↓ Clinic SBP  
↓ Clinic DBP  
Spinach 
beverage  
     
 ↓ Clinic SBP  
↓ Clinic DBP  
Beetroot juice 375 mg  
(6 mmol) 
3 h 
 
 
Nitrate: 53±10 y (12 M; 21 F) 
Placebo: 53±12 y (12 M; 22 F) 
Hypercholesterolaemic 
Normal Velmurugan 
2016 (50) 
 ↓ Clinic SBP  Spinach 220 mg  
(3.5 mmol) 
3.5 h 
 
58.8±7.6 y (6 M; 20 F) 
Healthy 
Optimal Liu 2013 
(78) 
 ↓ Clinic DBP  Beetroot juice 500 mg  
(8.1 mmol) 
2 h 
 
61±7 y(20 M) 
Overweight 
High-normal Joris 2013 
(79) 
 ↓ Clinic SBP  Spinach 182 mg 
(2.9 mmol) 
3.3 h 47±14 y (6 M; 24 F) 
Healthy 
Optimal Bondonno 
2012 (83) 
 ↓ Clinic SBP Potassium 
nitrate 
496 mg  
(8 mmol) 
3 h 
 
28±2 y (14) 
Healthy 
Optimal Bahra 2012 
(84) 
 ↓ Clinic SBP 
↓ Clinic DBP 
Potassium 
nitrate 
1488 mg  
(24 mmol) 
24 h 
 
23±1 y (8 M; 12 F) 
Healthy 
Optimal Kapil 2010 
(85) 
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 ↓ Clinic SBP 
↓ Clinic DBP 
Potassium 
nitrate 
248 mg, 744 
mg  
(4 mmol, 12 
mmol) 
3 h 
 
29±2 y (6)  
Healthy 
Optimal  
 ↓ Clinic SBP Beetroot juice 341 mg 
(5.5 mmol) 
3 h 25±1 y (9) 
Healthy 
Normal  
 ↓ Clinic SBP 
↓ Clinic DBP 
Beetroot juice 1395 mg  
(22.5 mmol) 
24 h 
 
26 ± 5 y (9 M; 5 F) 
Healthy 
Optimal Webb 2008 
(40) 
 ↓ Ambulatory 
DBP in T 
carriers only 
Beetroot bread 68 mg 
(1.1 mmol) 
6 h 
 
34±9 y (14 M) 
Healthy 
Normal  Hobbs 2014 
(77) 
 ↓ Ambulatory 
DBP  
Beetroot bread 68 mg  
(1.1 mmol) 
6 h 
 
31±2 y (23 M) 
Healthy 
Normal Hobbs 2013 
(80) 
 ↓ Ambulatory 
SBP 
↓ Ambulatory 
DBP 
Beetroot juice 0-707 mg 
(0-11.4 
mmol) 
24 h 31±3 y (18 M) 
Healthy 
High-normal Hobbs 2012 
(81) 
 ↓ Ambulatory 
SBP 
↓ Ambulatory 
DBP 
White 
beetroot-
enriched bread 
99 mg  
(1.6 mmol) 
24 h 
 
25±1 y (14 M) 
Healthy 
High-normal  
 ↓ Ambulatory 
SBP 
↓ Ambulatory 
DBP 
Red beetroot-
enriched bread 
112 mg  
(1.8 mmol)  
    
 ↓ Ambulatory 
SBP  
(M only) 
Beetroot juice 465 mg  
(7.5 mmol) 
24 h 
 
43±3 y (15 M; 15 F) 
Healthy 
High-normal Coles and 
Clifton 
2012 (82) 
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No effect No effect on 
clinic BP 
Beetroot gel 391 mg  
(6.3 mmol) 
3 h 27±2 y (4 M; 1 F) 
Healthy 
Optimal da Silva 
2016 (73) 
 No effect on 
clinic BP 
Beetroot juice 341 mg  
(5.5 mmol) 
2.5 h Nitrate: 21±1 y (5 M; 15 F) 
Placebo: 21±1 y (7 M; 13 F) 
Healthy 
Optimal Wightman 
2015 (74) 
 No effect on 
clinic BP 
Sodium nitrate 0.1-10 mg/kg 
body weight 
4 h 25±1 y (15 M) 
Healthy 
Optimal Rodriguez-
Mateos 
2015 (75) 
 No effect on 
clinic BP 
Beetroot juice 694 mg 
(11.2 mmol) 
2 h 57±10 y (5 M; 4 F) 
Heart failure 
Optimal Coggan 
2015 (63) 
 No effect on 
clinic BP 
Beetroot juice 310 mg  
(5 mmol) 
3 h 25±5 y (7 M; 4 F) 
Healthy 
Optimal Bakker 
2015 (76) 
 No effect on 
clinic BP 
Beetroot juice  738 mg  
(11.9 mmol) 
3 h Young: 27±6 y (11 M; 5 F) 
Old: 59±6 y (8 M; 7 F) 
Healthy 
Normal/high-
normal 
Shepherd 
2016 (69) 
 No effect on 
clinic BP 
Beetroot juice  403-434 mg 
(6.5-7.0 
mmol) 
2 h 23±3 y (20 M) 
Healthy 
Optimal Lefferts 
2016 (70) 
Screening/baseline blood pressure was based on criteria in the Australian guidelines for the diagnosis and management of hypertension in adults 
(150). BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure. 
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Table 2. Intervention studies investigating the chronic effects of inorganic nitrate on blood pressure in humans. 
 Blood 
pressure 
effect 
Nitrate source Nitrate dose Duration Subjects Screening/baseline 
blood pressure 
Reference 
Effect ↓ Clinic DBP Beetroot juice 450 mg/d  
(7.3 mmol/d) 
3 d 24±1 y (6 M) 
Healthy 
Normal Keen 2015 
(86) 
 ↓ Clinic, home 
and 
ambulatory 
SBP 
↓ Clinic, home 
and 
ambulatory 
DBP 
Beetroot juice 398 mg/d  
(6.4 mmol/d) 
 
28 d 
 
 
n=64 (26 M; 38 F) 
Nitrate: 58±14 y 
Placebo: 56±16 y 
Drug-naïve and treated 
hypertensive 
Grade 1 
hypertension 
Kapil 2015 
(87) 
 ↓ Clinic SBP High nitrate 
vegetables 
339±133 
mg/d 
(5.5±2.1 
mmol/d) 
7 d 
 
20±2 y (19 F) 
Healthy 
Optimal Ashworth 
2015 (88) 
 ↓ Home SBP 
 
No effect on 
clinic and 
ambulatory BP 
 
Beetroot juice 300-400 
mg/d  
(4.8-6.4 
mmol/d) 
21 d 
 
n=21 (12 M; 9 F) 
Beetroot:63±2 y 
Placebo: 61±1 y 
Older overweight 
Normal/high-
normal 
Jajja 2014 
(90) 
 ↓ Clinic SBP 
 
Sodium nitrate 9.3 mg/kg 
body 
weight/d 
28 d 
 
63±6 y (4 M; 7 F) 
Moderate cardiovascular risk 
High-normal Rammos 
2014 (89) 
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 ↓ Clinic DBP Japanese 
traditional diet 
18.8 
mg/kg/body 
weight/d 
 
10 d 
 
36±10 y (10 M; 15 F) 
Healthy 
Optimal 
 
Sobko 2010 
(92) 
 ↓ Clinic DBP  
 
Sodium nitrate 6.2 mg/kg 
body 
weight/d 
3 d 24 y (15 M; 2 F) 
Healthy 
Optimal 
 
Larsen 2006 
(93) 
No effect No effect on 
clinic BP 
 
Beetroot juice 375 mg/d  
(6 mmol/d) 
42 d Nitrate: 53±10 y (12 M; 21 F) 
Placebo: 53±12 y (12 M; 22 F) 
Hypercholesterolaemic  
Normal Velmurugan 
2016 (50) 
 No effect on 
clinic and 
ambulatory BP 
Beetroot juice 600 mg/d  
(9.7 mmol/d) 
7 d 62±5 y (14 M; 16 F) 
Overweight and obese 
Normal/high-
normal 
Lara 2015 
(65) 
 No effect on 
home and 
ambulatory BP 
Beetroot juice 434 mg/d  
(7 mmol/d) 
7 d 63±4 y (10 M; 17 F) 
Treated hypertensive 
High-normal Bondonno 
2015 (66) 
 No effect on 
clinic, home 
and 
ambulatory BP 
Green leafy 
vegetables 
300 mg/d 
(4.8 mmol/d) 
7 d 61±7 y (12 M; 26 F) 
Pre-hypertensive 
High-normal Bondonno 
2014 (67) 
 No effect on 
ambulatory BP 
Beetroot juice 465 mg/d  
(7.5 mmol/d) 
14 d 67±5 y (18 M; 9 F) 
T2DM 
Grade 1 
hypertension 
Gilchrist 
2013 (68) 
 No effect on 
clinic BP 
High nitrate 
diet 
155 mg/d  
(2.5 mmol/d) 
3 d 73±5 y (3 M; 5 F) 
Older 
High-normal Miller 2012 
(91) 
  Beetroot juice 527 mg/d 
(8.5 mmol/d) 
3 d  Normal  
  Combination 682 mg/d  
(11 mmol/d) 
3 d  High-normal  
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Screening/baseline blood pressure was based on criteria in the Australian guidelines for the diagnosis and management of hypertension in adults 
(150). BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus. 
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Table 3. Intervention studies investigating the acute effects of inorganic nitrate on endothelial function in humans. 
 FMD effect Nitrate source Nitrate dose Duration Subjects Reference 
Effect ↑ FMD Beetroot juice 375 mg  
(6 mmol) 
3 h 
 
Nitrate: 53±10 y (12 M; 21 F) 
Placebo: 53±12 y (12 M; 22 F) 
Hypercholesterolaemic 
Velmurugan 
2016 (50) 
 ↑ FMD Beetroot juice 310 mg 
(5 mmol) 
3 h 25±5 y (7 M; 4 F) 
Healthy 
Bakker 2015 
(76) 
 ↑ FMD Sodium nitrate 0.1-10 mg/kg 
body weight 
4 h 24±1 y (15 M) 
Healthy 
Rodriguez-
Mateos 2015 
(75) 
 ↑ FMD Beetroot juice 500 mg  
(8.1 mmol) 
2 h 61±7 y (20 M) 
Overweight 
Joris 2013 (79) 
 ↑ FMD Sodium nitrate 9.3 mg/kg 
body weight 
1.5 h 26±1 y (5 M; 5 F) 
Healthy 
Heiss 2012 
(112) 
 ↑ FMD Spinach 182 mg 
(2.9 mmol) 
4 h 47±14 y (6 M; 24 F) 
Healthy 
Bondonno 2012 
(83) 
No effect No effect Potassium 
nitrate 
496 mg  
(8 mmol) 
3 h 28±2 y (14) 
Healthy 
Bahra 2012 (84) 
FMD, flow-mediated dilatation. 
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Table 4. Intervention studies investigating the chronic effects of inorganic nitrate on endothelial function in humans. 
 FMD effect Nitrate 
source 
Nitrate dose Duration Subjects Reference 
Effect ↑ FMD Beetroot juice 375 mg/d  
(6 mmol/d) 
42 d Nitrate: 53±10 y (12 M; 21 F) 
Placebo: 53±12 y (12 M; 22 F) 
Hypercholesterolaemic 
Velmurugan 
2016 (50) 
 ↑ FMD Beetroot juice 398 mg/d  
(6.4 mmol) 
28 d n=64 (26 M; 38 F) 
Nitrate: 58±14 y 
Placebo: 56±16 y 
Drug-naïve and treated hypertensive 
Kapil 2015 (87) 
 ↑ FMD Sodium nitrate 9.3 mg/kg body 
weight/d 
28 d 63±6 y (4 M; 7 F) 
Moderate cardiovascular risk 
Rammos 2014 
(89) 
No effect No effect Beetroot juice 465 mg/d  
(7.5 mmol/d) 
14 d 67±5 y (18 M; 9 F) 
T2DM 
Gilchrist 2013 
(68) 
FMD, flow-mediated dilatation; T2DM, type 2 diabetes mellitus. 
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Table 5. Intervention studies investigating the acute effects of inorganic nitrate on ischemic reperfusion in humans. 
 Ischemic 
reperfusion 
effect 
Nitrate source Nitrate dose Duration Subjects Reference 
Effect Attenuated IR-
induced 
endothelial 
dysfunction 
Potassium 
nitrate 
1488 mg 
(24 mmol) 
3 h 25±1 y (12) 
Healthy 
Kapil 2010 (85) 
  Beetroot juice 341 mg  
(5.5 mmol) 
3 h   
 Attenuated IR-
induced 
endothelial 
dysfunction 
Beetroot juice 1395 mg  
(22.5 mmol) 
2 h 27±7 y (4 M; 6 F) 
Healthy 
Webb 2008 (40) 
IR, ischemic reperfusion. 
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Table 6. Intervention studies investigating the effects of inorganic nitrate on arterial stiffness in humans. 
 Arterial 
stiffness effect 
Nitrate source Nitrate dose Duration Subjects Reference 
Effect ↓ AIx (young 
only) 
Beetroot juice 583 mg  
(9.4 mmol) 
Acute (3 h) Young: 25±4 y (10 M; 3 F)  
Old: 64±5 y (9 M; 3 F) 
Healthy 
Hughes 2016 
(72) 
 ↓ PWV  
 
Potassium 
nitrate 
496 mg  
(8 mmol) 
Acute (3 h) 28±2 y (14) 
Healthy 
Bahra 2012 (84) 
 ↓ PWV  
↓ AIx 
Beetroot juice 375 mg/d 
(6 mmol) 
Acute (3 h) Nitrate: 53±10 y (12 M; 21 F) 
Placebo: 53±12 y (12 M; 22 F) 
Hypercholesterolaemic 
Velmurugan 
2016 (50) 
 ↓ PWV    Chronic (42 d)   
 ↓ PWV  
↓ AIx 
Beetroot juice 398 mg/d 
(6.4 mmol/d) 
 
Chronic (28 d) n=64 (26 M; 38 F) 
Nitrate: 58±14 y 
Placebo: 56±16 y 
Drug-naïve and treated hypertensive 
Kapil 2015 (87) 
 ↓ PWV  
↓ AIx 
Sodium nitrate 9.3 mg/kg 
body weight/d 
Chronic (28 d) 
 
63±6 y (4 M; 7 F) 
Moderate cardiovascular risk 
Rammos 2014 
(89) 
No effect No effect on 
PWV and AIx 
Beetroot juice  403-434 mg 
(6.5-7.0 mmol) 
Acute (2 h) 23±3 y (20 M) 
Healthy 
Lefferts 2016 
(70) 
 No effect on 
PWV and AIx 
Beetroot bread 68 mg  
(1.1 mmol) 
Acute (6 h) 31±2 y (23 M) 
Healthy 
Hobbs 2013 (80) 
 No effect on 
PWV and AIx 
Beetroot juice 500 mg  
(8.1 mmol) 
Acute (2 h) 61±7 y (20 M) 
Overweight 
Joris 2013 (79) 
 No effect on 
PWV and AIx 
Spinach 220 mg  
(3.5 mmol) 
Acute (3.5 h) 59±8 y (6 M; 20 F) 
Healthy 
Liu 2013 (78) 
 No effect on 
PWV 
Beetroot juice 600 mg/d  
(9.7 mmol/d) 
Chronic (7 d) 62±5 y (14 M; 16 F) 
Overweight and obese 
Lara 2015 (65) 
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 No effect on 
PWV and AIx 
Green leafy 
vegetables 
300 mg/d  
(4.8 mmol/d) 
Chronic (7 d) 61±7 y (12 M; 26 F) 
Pre-hypertensive 
Bondonno 2014 
(67) 
AIx, augmentation index; PWV, pulse wave velocity.  
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Table 7. Intervention studies investigating the effects of inorganic nitrate on platelet function in humans. 
 Platelet effect Nitrate source Nitrate dose Duration Subjects Reference 
Effect ↓ in platelet 
reactivity in 
males but not 
females 
Beetroot juice 192 mg  
(3.1 mmol) 
Acute (3 h) M: 26±1 y (12) 
F: 24±2 y (12) 
Healthy 
Velmurugan 2013 
(125) 
 ↓ in platelet 
reactivity in 
males but not 
females 
Potassium 
nitrate 
496 mg  
(8 mmol) 
Acute (3 h) M: 27±1 y (12) 
F: 29±2 y (12) 
Healthy 
 
 ↓ in platelet 
aggregation 
Beetroot juice 1054 mg  
(17 mmol) 
Acute (2.5 h) 31±2 y (5 M; 1 F) 
Healthy 
Webb 2008 (40) 
 ↓ in platelet 
aggregation 
Potassium 
nitrate 
124 mg  
(2 mmol) 
Acute (2.5 h) 18-44 y (4 M; 3 F) Richardson 2002 
(126) 
 ↓ in platelet 
aggregation  
Potassium 
nitrate 
31 mg, 124 mg  
(0.5 mmol, 2 
mmol) 
Acute (2.5 h) 18-44 y (3 M; 3 F)  
 ↓ in platelet-
monocyte 
aggregates  
Beetroot juice 375 mg/d  
(6 mmol/d) 
Chronic (42 d) Nitrate: 53±10 y (12 M; 21 F) 
Placebo: 53±12 y (12 M; 22 F) 
Hypercholesterolaemic 
Velmurugan 2016 
(50) 
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Table 8. Intervention studies investigating the effects of inorganic nitrate in animals. 
 Effect Nitrate source Background diet Nitrate dose Duration Animals Reference 
Blood 
pressure 
↓ MAP (6.7 
mmol  dose only) 
KNO3 in 
drinking water 
Not described 2.5 or 6.7 
mmol/kg/d 
3 w 
 
Hypoxia WT male mice 
(n≥8) 
Baliga 2012 
(151) 
 No change in 
MAP 
Hypoxia eNOS KO 
male mice (n≥8) 
 
 ↓ MAP NaNO3 in 
drinking water 
Not described 0.1 
mmol/kg/d 
8 w Rats (5≤n≥15) Carlstrom 
2010 (152) 
 ↓ MAP (1mM 
dose only) 
supplemented 
with NaNO3 
High-salt diet 0.1 or 1 
mmol/kg/d 
8-11 w UNX Male Sprague–
Dawley rats 
Carlstrom 
2011 (103) 
 Prevented ↑ in 
MAP 
NaNO3 in 
drinking water 
Not described 1 mmol/kg/d 8 w Male SH rats (n=6) Chien 2014 
(98) 
 No change in 
MAP 
Normotensive Wistar 
Kyoto rats (n=6) 
 
 ↓ MAP Supplemented 
with NaNO3 
High-fructose diet 1.8 
mmol/kg/d 
6 w Male Sprague–Dawley 
rats (n=8) 
Essawy 
2014 (100) 
 Prevented ↑ in 
MAP 
10 w 
from 
start 
Male Sprague–Dawley 
rats (n=8) 
 
 ↓ MAP NaNO3 in 
drinking water 
Standard chow 0.2 
mmol/kg/d 
1 w Male Sprague-Dawley 
rats (n=7) 
Petersson 
2009 (153) 
 ↓ MAP and ↓ 
DBP 
   5 d Male Sprague-Dawley 
rats 
 
 No change in 
MAP or SBP 
NaNO3 in 
drinking water 
Standard chow 0.8 
mmol/kg/d 
2 w Young male Sprague–
Dawley rats (n=8) 
Hezel 2016 
(101) 
 ↓ MAP and ↓ 
SBP 
0.3 
mmol/kg/d 
Old male Sprague–
Dawley rats (n=5) 
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 No change in 
SBP 
NaNO3 in 
drinking water 
Standard chow 0.1 g/L 8 w Male Wistar rats (n=8) Khalifi 
2015 (102) 
 ↓ SBP Diabetic Male Wistar 
rats (n=8) 
 
 No change in BP NaNO3 in 
drinking water 
Western-type diet 0.2 mmol/d 14 w LDL receptor KO mice 
(n=15) 
Marsch 
2016 (154) 
 Smaller rise in 
SBP 
Mg(NO3)2 in 
drinking water 
Not described 0.3 
mmol/kg/d 
4 w Male SH rats (n=7) Vilskersts 
2014 (99) 
 ↓ MAP (0.1mM 
dose only) 
↑ MAP (1mM 
dose only) 
NaNO3 in 
drinking water 
Standard chow 0.1 or 1 
mmol/kg/d 
8-10 w Male Sprague–Dawley 
rats (n=5-12) 
Carlstrom 
2015 (97) 
Vascular 
function 
↓ Ach-mediated 
vasorelaxation 
(1mM dose only) 
   2-4 w WT C57BL/6 mice 
(n=5-12) 
 
 No 
vasorelaxation 
    eNOS KO mice (n=5-
12) 
 
 ↑ Ach-mediated 
vessel relaxation 
(0.1 and 1 mmol 
dose only) 
NaNO3 in 
drinking water 
High-fat diet 0.1, 1 or 10 
mmol/kg/d 
10 w Male ApoE KO mice 
(n= 8-12) 
Bakker 
2016 (115) 
Ischaemic 
reperfusion 
↑ Perfusion 
recovery 
NaNO3 in 
drinking water 
Not described  5.0 
mmol/kg/d 
2 w Male NMRI mice or 
C57BL/6 mice (n=21-
23) 
Hendgen-
Cotta 2012 
(117) 
Platelet 
function 
↓ collagen 
induced platelet 
aggregation 
NaNO3 in 
drinking water 
Standard chow 1 g/L 1 w WT C57BL/6 mice 
(n≥5) 
eNOS KO mice (n≥5) 
Park 2013 
(127) 
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Ach, acetylcholine; ApoE, apolipoprotein e; eNOS, endothelial nitric oxide synthase; KO, knock-out; LDL, low density lipoprotein; MAP, 
mean arterial pressure; NMRI, Naval Medical Research Institute; NO, nitric oxide; NOS, nitric oxide synthase; SBP, systolic blood pressure; 
SH, spontaneously hypertensive; UNX, uninephrectomized; WT, wild-type. 
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Table 9. Intervention studies investigating the effects of inorganic nitrate on cerebral blood flow in humans. 
 Cerebral blood flow effect Nitrate source Nitrate dose Duration Subjects Reference 
Effect ↑ regional cerebral 
perfusion in frontal lobe 
white matter but no effect 
on global cerebral perfusion 
High nitrate diet 769 mg  
(12.4 mmol) 
Acute (24 h) 
 
75±7 y (14) 
Older 
Presley 2011 (129) 
No effect No effect on cerebral blood 
flow 
Sodium nitrate 6.2 mg/kg body 
weight/d 
Chronic (3 d) 
 
25±1 y (20 M) 
Healthy 
Aamand 2014 
(130) 
NOS, nitric oxide synthase. 
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Table 10. Observational epidemiological studies of dietary nitrate and cardiovascular-related health outcomes 
Study design and 
population 
Nitrate intake 
assessment 
Primary 
outcome 
Adjusted variables Results Reference 
15 y follow-up study 
n=1226  
Australian female older adults 
Diabetes and ASVD-free 
75.1±2.7 y 
FFQ ASVD mortality Model 1: Unadjusted. 
Model 2: Age and energy. 
Model 3: Age, BMI, physical 
activity, alcohol intake, history of 
smoking, socioeconomic status, 
calcium supplementation group, 
organic nitrate medication, 
antihypertensive medication, statin 
medication, low-dose aspirin, renal 
function, and energy intake. 
↓ ASVD 
mortality 
Blekkenhorst 
2017 (53) 
15 y follow-up study 
n=1226 
Australian female older adults 
Diabetes and ASVD-free 
75±3 y 
FFQ Ischaemic 
cerebrovascular 
disease 
hospitalisation 
and death  
Model 1: Unadjusted. 
Model 2: Age and energy. 
Model 3: Age, BMI, energy intake, 
alcohol intake, energy expended in 
physical activity, antihypertensive 
medication, statin medication, low-
dose aspirin medication, organic 
nitrate medication, history of 
smoking, and treatment. 
↓ ischaemic 
cerebrovascular 
disease 
hospitalisation 
and death 
Bondonno 
2017 (54) 
Cross-sectional and 3 y 
follow-up study 
n=1538 cross-sectional 
n=1229 follow-up 
Iranian male and female 
adults (57% female) 
FFQ eGFR and CKD  Model 1: age, sex, and BMI. 
Model 2: Additional adjustment for 
smoking, education, physical 
activity, diabetes, and hypertension. 
↓ eGFR, ↑ CKD 
(cross-sectional)  
 
No association 
for 3 year 
Mirmiran 
2016 (146) 
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38.0±12.0 y Model 3: Additional adjustment for 
dietary intake of energy, fibre, and 
potassium. 
follow-up of 
CKD 
5.8 y follow-up study 
n=2139 
Iranian male and female 
adults (54.6% male) 
T2DM-free 
38.9±12.6 y 
FFQ T2DM Model 1: Diabetes risk score.  
Model 2: Additional adjustment for 
dietary total fat, fibre, and vitamin C. 
 
No association  
 
Bahadoran 
2017 (147) 
3 y follow-up study 
Iranian male and female 
adults (57% female) 
38±12 y 
 
FFQ Hypertension Model 1: Adjusted for age and sex. 
Model 2: Additional adjustment for 
weight, 3-year weight change, 
smoking, education, physical 
activity, baseline SBP and DBP. 
Model 3: Additional adjustment for 
dietary intake of energy, fibre, 
sodium, potassium and processed 
meat. 
No association Golzarand 
2016 (145) 
ASVD, atherosclerotic vascular disease; BMI, body mass index; CKD, chronic kidney disease; DBP, diastolic blood pressure; eGFR, 
estimated glomerular filtration rate; FFQ, food frequency questionnaire; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus. 
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Figure legends: 
Figure 1. Observed beneficial effects of nitrate ingestion on cardiovascular-related health 
outcomes in human and animal studies. ASVD, atherosclerotic vascular disease; CVD, 
cardiovascular disease. 
